🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

US STOCKS-Drug stocks hit by Amazon health push, tech steadies Wall St

Published 28-06-2018, 09:03 pm
© Reuters.  US STOCKS-Drug stocks hit by Amazon health push, tech steadies Wall St
US500
-
DJI
-
FDX
-
ESRX
-
AMZN
-
MRVL
-
WBA
-
IXIC
-
CAVM
-
SPSY
-
SPXHC
-
SPLRCI
-
SPLRCT
-

* Drug stocks tumble after Amazon buys online pharmacy

* Amazon's delivery plans hit FedEx (NYSE:FDX) and UPS

* U.S. Q1 GDP growth revised down to 2 pct

* Accenture jumps after strong quarterly results

* Dow down 0.04 pct; S&P up 0.08 pct, Nasdaq up 0.20 pct (Changes comment, adds details, updates prices)

By Sruthi Shankar

June 28 (Reuters) - Amazon's foray into the pharmacy space sent drug stocks sliding on Thursday, but gains in financial and technology stocks helped Wall Street keep its footing.

Amazon.com AMZN.O said it would buy online pharmacy PillPack, sending shares of drug distributors and retailers tumbling. Boots Alliance WBA.O , already under pressure after its third-quarter earnings report, tumbled 9.3 percent and along with UnitedHealth's UNH.N 2 percent drop pulled the Dow Jones Industrial Average lower.

Shares of CVS Health CVS.N sank 8.8 percent, Rite Aid RAD.N fell 10.9 percent and Express Scripts ESRX.O was down 3.2 percent.

The S&P health sector .SPXHC dropped 0.61 percent, the most among the 11 S&P sectors, while Amazon gained 1.2 percent.

The U.S. economy slowed more than previously estimated in the first quarter, according to Commerce Department data that showed gross domestic product increased at a 2 percent annual rate in the period, instead of the 2.2 percent pace reported last month. revision came amid the weakest performance in consumer spending in nearly five years and with the United States engaged in tit-for-tat trade tariffs with its major trade partners, including China, Canada and the European Union.

"It's not unusual at this point in the quarter to have a little bit of a whacking in terms of economic numbers and corporate reports," said Stephen Lee, founding principal at Logan Capital Management in Ardmore, Pennsylvania.

"That whacking tends to get pulled with some of the political drama in the U.S. and around the world, and that seems to be what is moving things around."

At 11:15 a.m. ET the Dow Jones Industrial Average .DJI was down 9.96 points, or 0.04 percent, at 24,107.63, the S&P 500 .SPX was up 2.13 points, or 0.08 percent, at 2,701.76 and the Nasdaq Composite .IXIC was up 15.04 points, or 0.20 percent, at 7,460.13.

Amazon's burgeoning reach was not limited to just the health sector. Its plans to entice entrepreneurs to set up their own package-delivery businesses sent shares of United Parcel Service UPS.N and FedEx FDX.N skidding more than 2 percent. stocks drove the S&P industrial index .SPLRCI down 0.5 percent.

Six of the 11 major S&P sectors were higher, with the financial index .SPSY gaining 0.47 percent ahead of results from the second round of the Federal Reserve's stress test for banks and lenders.

The technology sector's .SPLRCT 0.58 percent jump gave the biggest boost to the market.

Accenture ACN.N rose 5.5 percent after the consulting and outsourcing services provider reported quarterly revenue and profit above estimates. Technology MRVL.O jumped 7 percent after the chipmaker said China cleared its $6 billion acquisition of rival Cavium CAVM.O , which rose 9.1 percent. issues outnumbered advancers for a 1.19-to-1 ratio on the NYSE and for a 1.18-to-1 ratio on the Nasdaq.

The S&P index recorded nine new 52-week highs and 23 new lows, while the Nasdaq recorded 23 new highs and 86 new lows.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.